FI115383B - Förfarande för isolering av Antiinflammatorisk faktor - Google Patents
Förfarande för isolering av Antiinflammatorisk faktor Download PDFInfo
- Publication number
- FI115383B FI115383B FI951980A FI951980A FI115383B FI 115383 B FI115383 B FI 115383B FI 951980 A FI951980 A FI 951980A FI 951980 A FI951980 A FI 951980A FI 115383 B FI115383 B FI 115383B
- Authority
- FI
- Finland
- Prior art keywords
- inflammatory
- factor
- milk
- maif
- inflammatory factor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39508—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from milk, i.e. lactoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96674192 | 1992-10-27 | ||
US07/966,741 US5352462A (en) | 1982-06-03 | 1992-10-27 | Anti-inflammatory factor, method of isolation, and use |
PCT/US1993/008935 WO1994009799A1 (en) | 1992-10-27 | 1993-09-22 | Anti-inflammatory factor, method of isolation, and use |
US9308935 | 1993-09-22 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI951980A0 FI951980A0 (sv) | 1995-04-26 |
FI951980A FI951980A (sv) | 1995-05-31 |
FI115383B true FI115383B (sv) | 2005-04-29 |
Family
ID=25511810
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI951980A FI115383B (sv) | 1992-10-27 | 1995-04-26 | Förfarande för isolering av Antiinflammatorisk faktor |
Country Status (15)
Country | Link |
---|---|
US (1) | US5352462A (sv) |
EP (1) | EP0746329B1 (sv) |
JP (3) | JPH08502515A (sv) |
KR (1) | KR100310899B1 (sv) |
AT (1) | ATE217797T1 (sv) |
AU (1) | AU679006B2 (sv) |
CA (1) | CA2146442C (sv) |
DE (1) | DE69331957T2 (sv) |
FI (1) | FI115383B (sv) |
IL (2) | IL107392A (sv) |
MX (1) | MX9306686A (sv) |
NO (1) | NO951570L (sv) |
NZ (1) | NZ256576A (sv) |
TW (1) | TW389695B (sv) |
WO (1) | WO1994009799A1 (sv) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5650175A (en) * | 1982-06-03 | 1997-07-22 | Stolle Research & Development Corporation | Anti-inflammatory factor, method of isolation, and use |
US5980953A (en) * | 1994-10-03 | 1999-11-09 | Stolle Milk Biologics, Inc. | Anti-inflammatory factor, method of isolation, and use |
DE19548221C1 (de) * | 1995-12-22 | 1997-05-15 | Biotest Pharma Gmbh | Orale Anwendung von Immunglobulin-Präparationen zur Behandlung und Prophylaxe chronischer Schmerzzustände |
DE69737191T2 (de) * | 1996-03-26 | 2007-11-08 | Arkion Life Sciences Llc., Wilmington | Entzündungshemmende Zusammensetzung aus Ei, Verfahren zur Isolierung und Verwendung |
US5772999A (en) * | 1996-07-30 | 1998-06-30 | Dcv Biologics, L.P. | Method of preventing, countering, or reducing NSAID-induced gastrointestinal damage by administering milk or egg products from hyperimmunized animals |
JP4451933B2 (ja) * | 1996-12-27 | 2010-04-14 | 住友化学株式会社 | 遺伝子操作による植物へのppo阻害性除草剤耐性付与法 |
AUPP494798A0 (en) | 1998-07-29 | 1998-08-20 | Pacific Biolink Pty Limited | Protective protein formulation |
AU6726500A (en) * | 1999-08-24 | 2001-03-19 | Nomoto, Kikuo | Methods of pasteurizing immune substance containing antiinflammatory factor and utilization thereof |
US6770280B1 (en) | 2001-11-15 | 2004-08-03 | Humanetics Corporation | Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product |
US20080026983A1 (en) * | 2006-07-28 | 2008-01-31 | Gardiner Paul T | Compositions and methods for alleviating joint pain and improving joint flexibility |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3128230A (en) * | 1961-04-04 | 1964-04-07 | Sunbury Milk Products Co | Milk having antibodies therein and process for producing same |
US3376198A (en) * | 1965-07-21 | 1968-04-02 | Collins Products Inc | Method of producing antibodies in milk |
GB1211876A (en) * | 1967-11-23 | 1970-11-11 | Twyford Lab Ltd | Improvements in and relating to prophylactic and therapeutic preparations |
CH590064A5 (sv) * | 1973-11-28 | 1977-07-29 | Biokema Sa | |
US4324782A (en) * | 1974-01-28 | 1982-04-13 | Beck Lee R | Dental caries inhibiting product of immunized cow's milk having antibodies specific to killed Streptococcus mutans cells |
US4732757A (en) * | 1978-02-06 | 1988-03-22 | Stolle Research And Development Corporation | Prevention and treatment of rheumatoid arthritis |
US4284623A (en) * | 1979-11-09 | 1981-08-18 | Beck Lee R | Method of treating inflammation using bovine milk |
EP0064103B1 (en) * | 1981-04-28 | 1985-11-06 | The Stolle Research And Development Corporation | Method of obtaining an anti-inflammatory bovine milk |
JPS58136137A (ja) * | 1982-02-08 | 1983-08-13 | Hitachi Ltd | 電界効果トランジスタを用いたインバータ回路 |
US4897265A (en) * | 1983-10-27 | 1990-01-30 | Stolle Research & Development Corporation | Method for treating disorders of the vascular and pulmonary systems |
US4879110A (en) * | 1983-10-27 | 1989-11-07 | Stolle Research And Development Corporation | Antihypertensive hyperimmune milk, production, composition, and use |
US4956349A (en) * | 1983-10-27 | 1990-09-11 | Stolle Research & Development Corporation | Anti-inflammatory factor, method of isolation, and use |
US4636384A (en) * | 1982-06-03 | 1987-01-13 | Stolle Research & Development Corporation | Method for treating disorders of the vascular and pulmonary systems |
US5242691A (en) * | 1982-06-03 | 1993-09-07 | Stolle Research & Development Corporation | Anti-inflammatory factor, method of isolation, and use |
JPS6049377A (ja) * | 1983-08-30 | 1985-03-18 | Canon Inc | 画像処理装置 |
JPS6135616A (ja) * | 1984-07-27 | 1986-02-20 | Tdk Corp | 電界効果トランジスタ駆動回路 |
JPS63139421A (ja) * | 1986-12-01 | 1988-06-11 | Fuji Electric Co Ltd | Mosfetのゲ−ト駆動回路 |
DE3785033T2 (de) * | 1987-07-21 | 1993-10-07 | Stolle Res & Dev | Verfahren zum Erhalten von immunregulierenden Faktoren mittels Säugetierimmunisierung. |
JPH022704A (ja) * | 1988-06-15 | 1990-01-08 | Matsushita Electric Works Ltd | 半導体スイッチング素子の駆動回路 |
JPH0250616A (ja) * | 1988-08-12 | 1990-02-20 | Matsushita Electric Works Ltd | トランジスタ駆動回路 |
US4897580A (en) * | 1989-06-20 | 1990-01-30 | Motorola Inc. | Amplifier drive circuit for inductive loads |
-
1992
- 1992-10-27 US US07/966,741 patent/US5352462A/en not_active Expired - Lifetime
-
1993
- 1993-09-22 EP EP93922286A patent/EP0746329B1/en not_active Expired - Lifetime
- 1993-09-22 NZ NZ256576A patent/NZ256576A/en not_active IP Right Cessation
- 1993-09-22 DE DE69331957T patent/DE69331957T2/de not_active Expired - Lifetime
- 1993-09-22 WO PCT/US1993/008935 patent/WO1994009799A1/en active IP Right Grant
- 1993-09-22 AT AT93922286T patent/ATE217797T1/de active
- 1993-09-22 CA CA002146442A patent/CA2146442C/en not_active Expired - Lifetime
- 1993-09-22 AU AU51340/93A patent/AU679006B2/en not_active Ceased
- 1993-09-22 JP JP6511051A patent/JPH08502515A/ja not_active Withdrawn
- 1993-09-22 KR KR1019950701624A patent/KR100310899B1/ko not_active IP Right Cessation
- 1993-10-25 IL IL10739293A patent/IL107392A/en not_active IP Right Cessation
- 1993-10-27 MX MX9306686A patent/MX9306686A/es not_active IP Right Cessation
- 1993-11-15 TW TW082109526A patent/TW389695B/zh not_active IP Right Cessation
-
1995
- 1995-04-25 NO NO951570A patent/NO951570L/no not_active Application Discontinuation
- 1995-04-26 FI FI951980A patent/FI115383B/sv active IP Right Grant
-
1997
- 1997-08-04 IL IL12146497A patent/IL121464A0/xx unknown
-
2005
- 2005-09-08 JP JP2005261108A patent/JP2006036785A/ja active Pending
-
2007
- 2007-10-25 JP JP2007277553A patent/JP2008074861A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2006036785A (ja) | 2006-02-09 |
MX9306686A (es) | 1994-06-30 |
NO951570D0 (no) | 1995-04-25 |
KR100310899B1 (ko) | 2001-12-17 |
KR950703983A (ko) | 1995-11-17 |
DE69331957T2 (de) | 2003-01-16 |
US5352462A (en) | 1994-10-04 |
AU679006B2 (en) | 1997-06-19 |
JP2008074861A (ja) | 2008-04-03 |
FI951980A (sv) | 1995-05-31 |
WO1994009799A1 (en) | 1994-05-11 |
IL121464A0 (en) | 1998-02-08 |
ATE217797T1 (de) | 2002-06-15 |
CA2146442A1 (en) | 1994-05-11 |
EP0746329A1 (en) | 1996-12-11 |
NO951570L (no) | 1995-06-26 |
TW389695B (en) | 2000-05-11 |
AU5134093A (en) | 1994-05-24 |
DE69331957D1 (de) | 2002-06-27 |
NZ256576A (en) | 1997-05-26 |
FI951980A0 (sv) | 1995-04-26 |
EP0746329A4 (en) | 1996-06-18 |
IL107392A (en) | 1998-09-24 |
IL107392A0 (en) | 1994-01-25 |
EP0746329B1 (en) | 2002-05-22 |
JPH08502515A (ja) | 1996-03-19 |
CA2146442C (en) | 2005-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU620289B2 (en) | An anti-inflammatory factor, method of isolation, and use | |
JP2008074861A (ja) | 抗炎症因子、単離法および使用 | |
AU660626B2 (en) | Anti-inflammatory factor, method of isolation, and use | |
JP2008133299A (ja) | 抗炎症性因子、単離の方法、および使用 | |
US5980953A (en) | Anti-inflammatory factor, method of isolation, and use | |
WO1996010410A9 (en) | Anti-inflammatory factor, method of isolation, and use | |
US10716850B2 (en) | Anti-inflammatory factor retentate, method of isolation, and use | |
NZ505177A (en) | Use of milk anti-Inflammatory factor (MAIF) to reduce tissue damage from inflammation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Ref document number: 115383 Country of ref document: FI |